Intuitive Surgical, Inc.
ISRG Healthcare Medical Instruments & Supplies
Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024. In the quarter to June 2026, revenue grew 18.5%, EPS grew 25.5% and free cash flow grew 69.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for five consecutive years, operating cash flow growth for three.
Follow ISRG
Intuitive Surgical, Inc. (ISRG) Free cash flow margin
Intuitive Surgical, Inc.'s free cash flow margin over the twelve months to 30 June 2026 was 29.6%, up 4.9 percentage points from fiscal 2025 (24.8%). Over the past ten years it has ranged from 10.5% (fiscal 2023) to 38.2% (fiscal 2016); the current reading is higher than 36% of that period. That is above the Medical Instruments & Supplies industry median of 1.08% and above the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Embed this chart
Annual newest first
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2025 | 24.8% | 9.14 |
| FY2024 | 15.6% | 5.09 |
| FY2023 | 10.5% | (4.88) |
| FY2022 | 15.4% | (15.25) |
| FY2021 | 30.7% | 4.42 |
| FY2020 | 26.2% | 0.05 |
| FY2019 | 26.2% | (0.19) |
| FY2018 | 26.4% | (4.00) |
| FY2017 | 30.4% | (7.80) |
| FY2016 | 38.2% | 7.76 |
Against its own ten years
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| ISRG Intuitive Surgical, Inc. | 29.6% |
| RMD ResMed Inc. compare | 28.8% |
| ALC Alcon compare | 14.7% |
| BDX Becton, Dickinson and Company compare | 14.3% |
| RGEN Repligen Corporation compare | 14.1% |
| WST West Pharmaceutical Services, Inc. compare | 13.1% |
| MDLN Medline Inc. compare | 7.75% |
| BAX Baxter International Inc. compare | 7.11% |
| SOLV Solventum Corporation compare | −1.42% |
| Medical Instruments & Supplies industry median | 1.08% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on ISRG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement